A study of non small cell lung cancer (NSCLC) patients with brain metastasis: A single centre experience

Organisation, W.H. GLOBOCAN. global cancer observatory, 2018. [cited 2022 08/03/22]; Available from: https://gco.iarc.fr/. Nayak, 2012, Epidemiology of brain metastases, Curr. Oncol. Rep., 14, 48, 10.1007/s11912-011-0203-y Gavrilovic, 2005, Brain metastases: epidemiology and pathophysiology, J. Neurooncol., 75, 5, 10.1007/s11060-004-8093-6 Riessk, 2013, Shifting paradigms in non-small cell lung cancer: an evolving therapeutic landscape, Am. J. Manag. Care, 19, s390 Ahmadzada, 2018, An update on predictive biomarkers for treatment selection in non-small cell lung cancer, J. Clin. Med., 7, 153, 10.3390/jcm7060153 Birring, 2005, Symptoms and the early diagnosis of lung cancer, Thorax, 60, 268, 10.1136/thx.2004.032698 Snee, 2021, Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative, BMJ Open, 11, 10.1136/bmjopen-2020-043442 Ali, 2013, Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases, Current Oncol., 20, 300, 10.3747/co.20.1481 Sperduto, 2017, Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA), JAMA Oncol., 3, 827, 10.1001/jamaoncol.2016.3834 Fenske, 2017, Systematic review of brain metastases in patients with non-small-cell lung cancer in the United States, European union, and Japan, Clin Lung Cancer, 18, 607, 10.1016/j.cllc.2017.04.011 Reck, 2016, Pembrolizumab versus Chemotherapy for PD-L1–positive non–small-cell lung cancer, N. Engl. J. Med., 375, 1823, 10.1056/NEJMoa1606774 Crinò, 2019, Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer, Lung Cancer, 129, 35, 10.1016/j.lungcan.2018.12.025 Rizzo, 2022, Impact of proton pump inhibitors and histamine-2-receptor antagonists on non-small cell lung cancer immunotherapy: a systematic review and meta-analysis, Cancers (Basel), 14, 10.3390/cancers14061404 Boolell, 2015, The evolution of therapies in non-small cell lung cancer, Cancers (Basel), 7, 1815, 10.3390/cancers7030864 Lamberti, 2020, Beyond EGFR, ALK and ROS1: current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma, Crit. Rev. Oncol. Hematol., 156, 10.1016/j.critrevonc.2020.103119 Ulahannan, 2017, Emerging treatment paradigms for brain metastasis in non-small-cell lung cancer: an overview of the current landscape and challenges ahead, Ann. Oncol, 28, 2923, 10.1093/annonc/mdx481 Excellence, N.I.f.H.a.C., Lung cancer: diagnosis and management CG121. 2011. Excellence, N.I.f.H.a.C., Lung cancer: diagnosis and management NG122. 2019. Kirakli, 2019, Radiotherapy of brain metastases from non-small cell lung cancer, J. Cancer Metastasis and Treatment, 5, 10 Mulvenna, 2016, Lancet, 388, 2004, 10.1016/S0140-6736(16)30825-X Spiro, 2004, Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life, Thorax, 59, 828, 10.1136/thx.2003.020164 Chi, 2010, Treatment of brain metastasis from lung cancer, Cancers (Basel), 2, 2100, 10.3390/cancers2042100 Goverment, B., People at the heart of care. Adult social care reform white paper D.o. Health, Editor. 2021. Pinto dos Santos, 2018, Big data, artificial intelligence, and structured reporting, Eur. Radiol. Experimental, 2, 42, 10.1186/s41747-018-0071-4 Lagerwaard, 1999, Identification of prognostic factors in patients with brain metastases: a review of 1292 patients, Int. J. Radiation Oncol.* Biol.* Phys., 43, 795, 10.1016/S0360-3016(98)00442-8 Hu, 2021, Brain metastases status and immunotherapy efficacy in advanced lung cancer: a systematic review and meta-analysis, Front. Immunol., 12, 10.3389/fimmu.2021.669398 Nayar, 2017, Leptomeningeal disease: current diagnostic and therapeutic strategies, Oncotarget, 8, 73312, 10.18632/oncotarget.20272 Sperduto, 2012, Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases, J. Clin. Oncol., 30, 419, 10.1200/JCO.2011.38.0527 Jin, 2017, Re-evaluating eligibility criteria for oncology clinical trials: analysis of investigational new drug applications in 2015, J. Clin. Oncol.: Official J. Am. Soc. Clin. Oncol., 35, 3745, 10.1200/JCO.2017.73.4186